End-of-day quote
Other stock markets
|
||
- EUR | - |
Jul. 01 | Active Biotech Enters Agreement for A Clinical Study of Tasquinimod in Myelofibrosis | CI |
May. 22 | Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug | MT |
- Stock Market
- Equities
- ACTI Stock
- BTPC Stock
- News Active Biotech AB
- Other languages